Spero therapeutics to provide business update and report first quarter 2023 financial results on thursday, may 11, 2023

Cambridge, mass., may 04, 2023 (globe newswire) -- spero therapeutics, inc. (nasdaq: spro), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (mdr) bacterial infections, today announced that it will host a conference call and live audio webcast on thursday, may 11, 2023 at 4:30 p.m. et to report its first quarter 2023 financial results and provide an update on its business and pipeline.
SPRO Ratings Summary
SPRO Quant Ranking